Condition: Hepatic Insufficiency · Liver Diseases · Sponsor: Incyte Corporation
This study will be conducted to assess the safety and pharmacokinetics of INCB123667 when administered orally to adult participants with moderate or severe hepatic impairment.
This description comes directly from the study's public registry record.
Incyte Corporation Call Center (US) · 1.855.463.3463 · medinfo@incyte.com
Incyte Corporation Call Center (ex-US) · +800 00027423 · eumedinfo@incyte.com
Always discuss trial participation with your own doctor first.
| Arizona Clinical Trials - the Institute For Liver Health | Chandler, Arizona, United States | Recruiting |
| Orlando Clinical Research Center | Orlando, Florida, United States | Recruiting |
| Texas Liver Institute - American Research Corporation | San Antonio, Texas, United States | Recruiting |
| Pinnacle Clinical Research | San Antonio, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07559474